{"id":"W3171517418","doi":"10.1016/s0140-6736(21)00797-2","title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2927,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Medicine; Gastric adenocarcinoma; Gastro-; Chemotherapy; Nivolumab; Internal medicine; Gastroenterology; Open label; Adenocarcinoma; Gastroesophageal Junction; Oncology; Clinical trial; Cancer; Reflux; Immunotherapy; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001569715,0.002067124,0.003254962,0.0003867145,0.0003932741,0.001283234,0.001197572,0.002125001,0.007684815],"category_scores_gemma":[0.001683507,0.0007426777,0.003276245,0.0003399473,0.001261621,0.001339519,0.0005315502,0.004241104,0.001376254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001310294,"about_ca_system_score_gemma":0.0009660908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001861719,"about_ca_topic_score_gemma":0.00460943,"domain_scores_codex":[0.9995345,0.0002328726,0.00002152301,0.0001028049,0.00002679926,0.00008151009],"domain_scores_gemma":[0.999243,0.0002362806,0.0001381896,0.00005648517,0.00003978236,0.0002862618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9821545,0.003466672,0.0003371595,0.000600995,0.001004552,0.00002510499,0.00003688836,0.0003926591,0.00119256,0.00008408963,0.000835203,0.009869664],"study_design_scores_gemma":[0.9520676,0.04560302,0.0008094803,0.00003450251,0.0004447921,0.00002280825,0.00001901086,0.0003054004,0.0001692471,0.0001341778,0.0003766627,0.0000132918],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830275,0.007083546,0.0006160243,0.001110357,0.001512469,0.002769847,0.001374673,0.0001539528,0.002351668],"genre_scores_gemma":[0.9818896,0.003773522,0.001514689,0.001732364,0.0005885524,0.002775828,0.00159045,0.00004119746,0.006093894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007684815,"threshold_uncertainty_score":0.02570832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05805096571869594,"score_gpt":0.3440784328444417,"score_spread":0.2860274671257457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}